(Press-News.org) DURHAM, N.C. – A drug designed to shield the heart from injury during bypass surgery failed to reduce deaths, strokes and other serious events among patients at high risk of complications, according to a large, prospective study lead by researchers at Duke University Medical Center.
But the international study also produced a surprising silver lining. As reported in the July 11 issue of the Journal of the American Medical Association, the researchers discovered that complications among bypass surgery patients were far less frequent than previously reported.
"We expected about 10 percent of patients were at high risk for complication following coronary artery bypass grafting," said Mark F. Newman, M.D., chairman of the Department of Anesthesiology at Duke and lead author of the study. "But the actual risk was 5 percent. What that means is cardiac surgery has gotten much safer, even for high-risk patients."
Newman said surgical management of patients undergoing coronary artery bypass grafting (CABG) has improved worldwide in the past decade.
The study, which began in 2009, tested a drug called acadesine in a Phase III trial that was one of the largest involving a surgical procedure. The primary objective was to determine whether acadesine would cut the rate of complications from CABG – the most common type of open heart surgery in the United States. The procedure is highly successful in restoring blood flow to the heart caused by blockages, but strokes, ventricular damage and death can result even after successful surgery.
One cause of complications is called ischemia reperfusion injury, which stems from changes that occur to tissue starved of oxygen during the surgery, when blood vessels are clamped to establish the grafts. This period of oxygen deprivation triggers inflammation and cell death once blood flow is restored.
Earlier evidence from smaller studies suggested acadesine, given before, during and after surgery, could offer protection by easing some of the inflammatory responses that kill cells. Most of those studies occurred before 1997, however, when the rate of serious complications was 10 percent or greater.
Newman and colleagues at 300 sites in seven countries randomly assigned patients to receive the trial drug or a harmless placebo, and provided followup for a month. The group found that the drug was no better than placebo at protecting people from complications, with five percent of patients having a severe event within that month regardless of taking acadesine or a mock treatment. The study, funded by the manufacturer Merck, was halted early based on a prespecified interim analysis after 3,080 patients were enrolled.
Still, the 5 percent complication rate was good news, Newman said. It is likely the result of improved surgical methods in recent years, including better anesthesia and advances in surgical and heart-lung machine management.
"A lot of things have played a part in the gradual improvement of outcomes over the years," Newman said. "We wish we had a drug that could help with ischemia/reperfusion injury – and that remains something that would benefit patients tremendously -- but we have made strides in other areas. As a result, older, sicker patients are now undergoing cardiac surgery with very good results."
Newman also said that support for publication of a negative study by the sponsor, Merck, and by the publisher JAMA, is an important step in defining the appropriate therapy for heart surgery patients going forward.
INFORMATION:
In addition to Newman, study authors include: Robert A. Harrington, Jennifer A. White and Tammy L. Reece of Duke; T. Bruce Ferguson of East Carolina Heart Institute; Giuseppe Ambrosio of the University of Perugia School of Medicine; Joerg Koglin and Armando Lira of Merck Sharp & Dohme Corp.; Nancy A. Nussmeier of SUNY Upstate Medical University; Ronald G. Pearl of Stanford University School of Medicine; Bertram Pitt of the University of Michigan School of Medicine; Andrew S. Wechsler of Drexel University College of Medicine; and Richard D. Weisel of University Health Network, Toronto.
Several authors, including Newman, reported receiving grant support, honoraria, consulting fees and/or travel reimbursement from Schering-Plough/Merck.
END
People who are born deaf process the sense of touch differently than people who are born with normal hearing, according to research funded by the National Institutes of Health. The finding reveals how the early loss of a sense— in this case hearing—affects brain development. It adds to a growing list of discoveries that confirm the impact of experiences and outside influences in molding the developing brain. The study is published in the July 11 online issue of The Journal of Neuroscience.
The researchers, Christina M. Karns, Ph.D., a postdoctoral research associate in ...
The cancer drug bevacizumab (Avastin®) offers only a modest benefit in delaying disease progression in patients with advanced stage breast cancer, according to a systematic review by Cochrane researchers. The researchers assessed the efficacy of bevacizumab in combination with chemotherapy, an established cancer treatment in this indication, and found no overall survival benefit when adding bevacizumab to chemotherapy.
Breast cancer is the most common cause of cancer death among women. If it spreads to other parts of the body it is referred to as "metastatic" and the ...
Taking iron supplements one to three times a week instead of every day is just as effective at preventing anaemia in pregnant women, according to the findings of a new Cochrane systematic review. The authors of the review also showed that women experienced fewer side effects when taking iron supplements intermittently rather than daily.
Lack of iron can cause anaemia in pregnant women, potentially increasing the risk of complications at delivery. It may also be harmful to their babies, through increased risk of low birth weight and even delayed growth and development ...
People at high risk of HIV infection can reduce their risk of acquiring the disease by taking antiretroviral drugs, according to Cochrane researchers. In an update of a systematic review first published in 2009, the researchers found that uninfected people in relationships with HIV-infected partners, men who have sex with men and those in other high risk groups are at a lower risk of becoming infected with the virus if they regularly take drugs that are normally prescribed to treat people with HIV.
Antiretroviral therapy (ART) is the standard drug treatment for HIV in ...
COLUMBIA, Mo. -- Computer networks are the battlefields in cyberwarfare, as exemplified by the United States' recent use of computer viruses to attack Iran's nuclear program. A computer model developed at the University of Missouri could help military strategists devise the most damaging cyber attacks as well as guard America's critical infrastructure. The model also could benefit other projects involving interconnected groups, such as restoring ecosystems, halting disease epidemics and stopping smugglers.
"Our model allows users to identify the best or worst possible ...
WASHINGTON — Researchers at Georgetown University Medical Center appear to have solved the mystery of why some patients infected with HIV, who are using antiretroviral therapy and show no signs of AIDS, develop serious depression as well as profound problems with memory, learning, and motor function. The finding might also provide a way to test people with HIV to determine their risk for developing dementia.
They say the answer, published in the July 11 issue of the Journal of Neuroscience, may ultimately lead to a therapeutic solution that helps these patients as well ...
A multi-institutional team of researchers that included scientists with the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) has created the first artificial molecules whose chirality can be rapidly switched from a right-handed to a left-handed orientation with a beam of light. This holds potentially huge possibilities for the application of terahertz technologies across a wide range of fields, including biomedical research, homeland security and ultrahigh-speed communications.
Chirality is the distinct left/right orientation or "handedness" ...
King penguins tolerate some, but not all, human interference. Research published in BioMed Central's open access journal, BMC Ecology, investigates the adjustment of a king penguin colony on the protected Possession island in the subantarctic Crozet Archipelago to over 50 years of constant human disturbance.
A team of researchers from the University of Strasbourg, the Centre National de la Recherche Scientifique (CNRS) and the University of Lausanne, compared 15 king penguins (Aptenodytes patagonicus) breeding in areas disturbed daily by humans and 18 penguins breeding ...
The ability for substances to pass through the blood-brain barrier is increased after adult stroke, but not after neonatal stroke, according to a new study the UCSF that will be published July 11 in the Journal of Neuroscience.
The novel findings may have major implications for drug development and the treatment of neonatal stroke, the researchers said.
The blood-brain barrier is selectively permeable and blocks unwanted molecules from entering into the brain. The selectivity is achieved through fine coordination in function of many transporting systems in endothelial ...
Research: Long term alcohol intake and risk of rheumatoid arthritis in women: a population based cohort study
Moderate consumption of alcohol is associated with a reduced risk of developing rheumatoid arthritis, suggests a study published on bmj.com today.
The results show that women who regularly consume more than three alcoholic drinks a week for at least 10 years have about half the risk of developing rheumatoid arthritis compared with non-drinkers.
After adjusting for factors such as age, smoking and dietary habits, women who reported drinking more than three ...
